Clastogenicity of quinoline and monofluorinated quinolines in Chinese hamster lung cells

Journal of Health Science

Volumn 53, Issue 3, 2007, Pages 325-328

  Suzuki, Takayoshi ^a   Takeshita, Kenji ^a   Saeki, Ken Ichi ^b   Kadoi, Minoru ^b   Hayashi, Makoto ^a   Sofuni, Toshio ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Chromosomal aberration; Fluoroquinoline; Micronucleus test; Quinoline

Indexed keywords

3 FLUOROQUINOLINE; 5 FLUOROQUINOLINE; 6 FLUOROQUINOLINE; 8 FLUOROQUINOLINE; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; METABOLIC ACTIVATION; MICRONUCLEUS; MUTAGENICITY; NONHUMAN;

CRICETULUS GRISEUS;

EID: 34249798720     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.53.325     Document Type: Article

References (26)

1. Hirao, K., Shinohara, Y., Tsuda, H., Fukushima, S., Takahashi, M. and Ito, N. (1976) Carcinogenic activity of quinoline on rat liver. Cancer Res., 36, 329-335.
2. Shinohara, Y., Ogiso, T., Hananouchi, M., Nakanishi, K., Yoshimura, T. and Ito, N. (1977) Effect of various factors on the induction of liver tumours in animals by quinoline. Jpn. J. Cancer Res., 68, 785-796.
3. Nagao, M., Yahagi, T., Seino, Y., Sugimura, T. and Ito, N. (1977) Mutagenicities of quinoline and its derivatives. Mutat. Res., 42, 335-342.
4. Takahashi, K., Kamiya, M., Sengoku, Y., Kohda, K. and Kawazoe, Y. (1988) Deprivation of the mutagenic property of quinoline: Inhibition of mutagenic metabolism by fluorine substitution. Chem. Pharm. Bull., 36, 4630-4633.
5. Kamiya, M., Sengoku, Y., Takahashi, K., Kohda, K. and Kawazoe, Y. (1990) Antimutagenic structure modification of quinoline: Fluorine-substitution at position-3. In Antimutagenesis and Anticarcinogenesis, vol. II, (Kuroda, Y., Shankel, D. M. and Waters, M. D., Eds.), Springer New York pp. 441-446.
6. Saeki, K., Kawai, H., Kawazoe, Y. and Hakura, A. (1997) Dual stimulatory and Inhibitory effects of fluorine-substitution on mutagenicity: An extension of the enamine epoxide theory for activation of the quinoline nucleus. Biol. Pharm. Bull., 20, 646-650.
7. LaVoie, E. J., Tulley-Freiler, L., Bedenko, V. and Hoffmann, D. (1983) Mutagenicity of substituted phenanthrenes in Salmonella typhinurium. Mutat. Res., 116, 91-102.
8. Hecht, S. S., LaVoie, E. J., Bedenko, V., Pingaro, L., Katayama, S., Hoffmann, D., Sardella, D. J., Boger, E. and Lehr, R. E. (1981) Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo[a,i]pyrene. Cancer Res., 41, 4341-4345.
9. Hubenman, E. and Slag, T. J. (1979) Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz[a]anthracene. Cancer Res., 39, 411-414.
10. Diamond, L., Chain, K., Harvey, R. G. and DiGiovanni, J. (1984) Mutagenic activity of methyland fluoro-substituted derivatives of polycyclic aromatic hydrocarbons in a human hepatoma cellmediated assay. Mutat. Res., 136, 65-72.
11. Miller, E. C. and Miller, J. A. (1960) The carcinogenicity of fluoro derivatives of 10-methyl-1,2-benzanthracene: 3- and 4-monofluoro derivatives. Cancer Res., 20, 133-137.
12. Saeki, K., Kadoi, M., Kawazoe, Y., Futakuchi, M., Tiwawech, D. and Shirai, T. (1997) Modification of the carcinogenic property of quinoline, a hepatocarcinogen, by fluorine atom substitution: evaluation of carcinogenicity by a medium-term assay. Biol. Pharm. Bull., 20, 40-43.
13. Miyata, Y., Saeki, K., Kawazoe, Y., Hayashi, M., Sofuni, T. and Suzuki, T. (1998) Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ transgenic mice. Mutat. Res., 414, 165-169.
14. Roe, A. and Hawkins, G. F. (1949) The preparation of heterocyclic fluorine compounds by the Schiemann reaction.II: The monofluoroquinolines. J. Am. Chem. Soc., 71, 1785-1786.
15. Gerson, H., McNeil, M. W., Parmegiani, R. and Godfrey, P. K. (1972) Secondary mechanisms of antifungal action of substituted 8-quinolinols.3: 5,7,8-Substituted quinolines. J. Med. Chem., 15, 105-106.
16. Matsuoka, A., Hayashi, M. and Ishidate, M. Jr. (1979) Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat. Res., 66, 277-290.
17. Ishidate, M. Jr., Ed. (1988) Data Book of Chromosomal Aberration Test In Vitro, Revised Edition, Elsevier/L.I.C., Amsterdam/Tokyo.
18. Matsuoka, A., Sofuni, T., Miyata, N. and Ishidate, M. Jr. (1991) Clastgenicity of 1-nitropyrene, dinitropyrene, fluorene and mononitrofluorenes in cultured Chinese hamster cells. Mutat. Res., 259, 103-110.
19. Matsuoka, A., Yamazaki, N., Suzuki, T., Hayashi, M. and Sofuni, T. (1993) Evaluation of the micronucleus test using a Chinese hamster cell line as an alternative to the conventional in vitro chromosomal aberration test. Mutat. Res., 272, 223-236.
20. Tada, M., Takahashi, K. and Kawazoe, Y. (1982) Metabolites of quinoline, a hepatocarcinogen, in a subcellular microsomal system. Chem. Pharm. Bull., 30, 3834-3837.
21. Tada, M., Takahashi, K. and Kawazoe, Y. (1980) Binding of quinoline to nucleic acid in a subcellular microsomal system. Chem.-Biol. Interact., 29, 257-266.
22. Suzuki, T., Miyata, Y., Saeki, K., Kawazoe, Y., Hayashi, M. and Sofuni, T. (1998) In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: Evidence for its in vivo genotoxicity. Mutat. Res., 412, 161-166.
23. Saeki, K., Takahashi, K. and Kawazoe, Y. (1993) Metabolism of mutagenicity-deprived 3-fluoroquinoline: Comparison with mutagenic quinoline. Biol. Pharm. Bull., 16, 232-234.
24. Willems, M. I., Dubois, G., Boyd, D. R., Davies, R. J. H., Hamilton, L., McCullough, J. J. and van Bladeren, P. J. (1992) Comparison of the mutagenicity of quinoline and all monohydroxyquinolines with a series of arene oxide, trans-dihydrodiol, diol epoxide, N-oxide and arene hydrate derivatives of quinoline in the Ames/Salmonella microsome test. Mutat. Res., 278, 227-236.
25. Miller, B., Potter-Locher, F., Seelbach, A., Stopper, H., Utesch, D. and Madle, S. (1998) Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test. Gesellschaft fur Umwelt-Mutations-forschung. Mutat. Res., 410, 81-116.
26. Matsushima, T., Hayashi, M., Matsuoka, A., Ishidate, M. Jr., Miura, K. F., Shimizu, H., Suzuki, Y., Morimoto, K., Ogura, H., Mure, K., Koshi, K. and Sofuni, T. (1999) Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis, 14, 569-580.